Commonwealth Equity Services’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.55M | Buy |
|
|||||
|
2025
Q2 | $630K | Buy |
|
|||||
|
2025
Q1 | $300K | Buy |
|
|||||
|
2024
Q4 | $359K | Buy |
|
|||||
|
2024
Q3 | $502K | Sell |
|
|||||
|
2024
Q2 | $616K | Sell |
|
|||||
|
2024
Q1 | $952K | Buy |
|
|||||
|
2023
Q4 | $993K | Buy |
|
|||||
|
2023
Q3 | $962K | Buy |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | $1.05K | Buy |
|
|||||
|
2022
Q4 | $948K | Buy |
|
|||||
|
2022
Q3 | $1.04M | Sell |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $1.88M | Sell |
|
|||||
|
2021
Q4 | $3.14M | Buy |
|
|||||
|
2021
Q3 | $3.54M | Sell |
|
|||||
|
2021
Q2 | $4.39M | Buy |
|
|||||
|
2021
Q1 | $1.99M | Buy |
|
|||||
|
2020
Q4 | $1.34M | Buy |
|
|||||
|
2020
Q3 | $480K | Buy |
|
|||||
|
2020
Q2 | $502K | Sell |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | $322K | Sell |
|
|||||
|
2019
Q3 | $311K | Buy |
|
|||||
|
2019
Q2 | $369K | Buy |
|
|||||
|
2019
Q1 | $241K | Buy |
|
|||||
|
2018
Q4 | $148K | Buy |
|
|||||
|
2018
Q3 | $257K | Sell |
|
|||||
|
2018
Q2 | $258K | Sell |
|
|||||
|
2018
Q1 | $204K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $281K | Buy |
|
|||||
|
2017
Q2 | $172K | Buy |
|
|||||
|
2017
Q1 | $147K | Sell |
|
|||||
|
2016
Q4 | $142K | Buy |
|